<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <title>FERTIN_I</title>
    <meta name="title" content="NHANES 2015-2016: Ferritin  Data Documentation, Codebook, and Frequencies" />
    <link rel="stylesheet" href="https://wwwn.cdc.gov/nchs/nhanes/css/documentation.css" />
  </head>
  <body class="nhanes-doc">
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Laboratory_Method_Files">Laboratory Method Files</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#References">References</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <ul id="CodebookLinks">
              <li>
                <a href="#SEQN">SEQN - Respondent sequence number</a>
              </li>
              <li>
                <a href="#LBXFER">LBXFER - Ferritin (ng/mL)</a>
              </li>
              <li>
                <a href="#LBDFERSI">LBDFERSI - Ferritin (ug/L)</a>
              </li>
            </ul>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2015-2016 Data Documentation, Codebook, and Frequencies</h2>
        <h3>Ferritin  (FERTIN_I)</h3>
        <h4> Data File: FERTIN_I.xpt</h4>
        <h5 class="left">First Published: May 2019</h5>
        <h5 class="right">Last Revised: NA</h5>
        <h5 class="specialnote">Note: See Analytic Note describing the change in instrumentation in the 2015-2016 survey cycle.</h5>
      </div>
      <div id="Sections">
        <h2 id="Component_Description">Component Description</h2><p style="line-height: 15.95pt;">The objectives of this component are: 1) to provide data for monitoring secular trends in&nbsp; measures of nutritional status in the U.S. population; 2) to evaluate the effects of people's habits and behaviors, such as physical activity and the use of alcohol, tobacco, and dietary supplements on nutritional status; and 3) to evaluate the effect of changes in nutrition and public health policies, including welfare reform legislation, food fortification policy, and child nutrition programs, on the nutritional status of the U.S. population. These data will be used to estimate deficiencies and toxicities of specific nutrients in the population and subgroups, to provide population reference data, and to estimate the contribution of diet, supplements, and other factors to serum levels of nutrients. Data will be used for research to further define nutrient requirements, as well as optimal levels for disease prevention and health promotion.</p><h2 id="Eligible_Sample">Eligible Sample</h2><p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Examined
participants aged 1 to 5 years were eligible, and female participants aged 12
to 49 years were eligible. </p><h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2><p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 0pt;">The method for measurement of Ferritin on the Roche Elecsys-170 is a
sandwich principle with a total duration time of 18 minutes. The 1st incubation
uses 10 uL of sample, a ferritin-specific antibody and a labeled
ferritin-specific antibody to form a sandwich complex. The 2nd incubation
occurs after the addition of microparticles that cause the complex to bind to
the solid phase. The reaction mixture is aspirated into the measuring cell
where the microparticles are magnetically captured onto the surface of the
electrode. Unbound substances are then removed. Application of a voltage to the
electrode then induces chemiluminescent emission, which is measured by a
photomultiplier. Results are determined via a calibration curve. </p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 0pt;">&nbsp;</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 0pt;">Refer to the
Laboratory Method Files section for a detailed description of the laboratory
methods used.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 0pt;">&nbsp;</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 0pt;">There were no changes
to the lab method or lab site for this component in the NHANES 2015-2016 cycle.
However, there were changes to the lab equipment. In 2016, the laboratory
instrumentation changed from the Roche Elecsys-170 to the Roche e601
instrument.<br />
</p><h2 id="Laboratory_Method_Files">Laboratory Method Files</h2>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2015/labmethods/FERTIN_I_MET.pdf">Ferritin Laboratory Procedure Manual</a>
          <span> (May 2019)</span>
        </p>
        <h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2><p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Serum samples were
processed, stored, and shipped to the Division of Laboratory Sciences, National
Center for Environmental Health, and Centers for Disease Control and Prevention,
Atlanta, GA for analysis.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Detailed instructions
on specimen collection and processing are discussed in the <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/manuals/2016_MEC_Laboratory_Procedures_Manual.pdf">NHANES Laboratory Procedures Manual
(LPM)</a>. Vials were stored under appropriate frozen (&ndash;30&deg;C) conditions
until they are shipped to National Center for Environmental Health for testing.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">The NHANES quality
assurance and quality control (QA/QC) protocols meet the 1988 Clinical
Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed
in the <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/manuals/2016_MEC_Laboratory_Procedures_Manual.pdf">NHANES LPM</a>. </p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;"><b>Mobile Examination Centers (MECs)</b></p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Laboratory team performance is monitored using several
techniques. NCHS and contract consultants use a structured competency
assessment evaluation during visits to evaluate both the quality of the
laboratory work and the quality-control procedures. Each laboratory staff member
is observed for equipment operation, specimen collection and preparation;
testing procedures and constructive feedback are given to each staff member.
Formal retraining sessions are conducted annually to ensure that required skill
levels were maintained.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;"><b>Analytical Laboratories</b></p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">NHANES uses several methods to monitor the quality of the
analyses performed by the contract laboratories. In the MEC, these methods
include performing blind split samples collected during &ldquo;dry run&rdquo; sessions. In
addition, contract laboratories randomly perform repeat testing on 2% of all
specimens.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">NCHS developed and distributed a quality control protocol
for all CDC and contract laboratories, which outlined the use of Westgard rules
(Westgard,
et al. 1981)
when running NHANES specimens. Progress reports containing any problems
encountered during shipping or receipt of specimens, summary statistics for
each control pool, QC graphs, instrument calibration, reagents, and any special
considerations are submitted to NCHS quarterly. The reports are reviewed for
trends or shifts in the data. The laboratories are required to explain any
identified areas of concern.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">All QC procedures recommended by the manufacturers were
followed. Reported results for all assays meet the Division of Laboratory
Sciences&rsquo; quality control and quality assurance performance criteria for
accuracy and precision, similar to the Westgard rules (Caudill, et al. 2008).</p><h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2><p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 0pt;">The data were reviewed. Incomplete data or improbable values were sent to
the performing laboratory for confirmation.<br />
<br />
One calculated variable (LBDFERSI) was created in this data file, using the formula
as follows: </p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 0pt;"><br />
<b style="mso-bidi-font-weight: normal;">LBDFERSI</b>: The ferritin measurement
in ng/mL (LBXFER) was converted to &micro;g/L (LBDFERSI) by multiplying LBXFER by 1.0
(rounded to 3 significant figures). </p>
<br /><h2 id="Analytic_Notes">Analytic Notes</h2><p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Refer to the <a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overview.aspx?BeginYear=2015">2015-2016 Laboratory Data Overview</a>
for general information on NHANES laboratory data.</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Please refer to the NHANES <a href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx">Analytic Guidelines </a>and the on-line NHANES <a href="https://www.cdc.gov/nchs/tutorials/">Tutorial</a> for details
on the use of sample weights and other analytic issues.<br />
</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;"><b>Demographic and Other Related Variables</b></p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">The analysis of NHANES laboratory data must be conducted
using the appropriate survey design and demographic variables. The <a href="https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Demographics&amp;CycleBeginYear=2015">NHANES 2015-2016 Demographics File</a>
contains demographic data, health indicators, and other related information
collected during household interviews as well as the sample design variables. The
recommended procedure for variance estimation requires use of stratum and PSU
variables (SDMVSTRA and SDMVPSU, respectively) in the demographic data file.
&nbsp;</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">The <a href="https://wwwn.cdc.gov/nchs/nhanes/2015-2016/fastqx_i.htm">Fasting
Questionnaire</a>&nbsp;File includes auxiliary information, such as fasting
status, length of fast, and the time of venipuncture. </p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">This laboratory data file can be linked to the other NHANES
data files using the unique survey participant identifier (i.e., SEQN).</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;"><b>Detection Limits</b></p>
<p style="line-height: 150%; margin-top: 0in; margin-right: 0in; margin-bottom: 10pt;">The
detection limits were constant for all of the analytes in the data set. Two
variables are provided for each of these analytes. The variable name ending &ldquo;LC&rdquo;
(ex., LBDFERLC) indicates whether the result was below the limit of detection:
the value &ldquo;0&rdquo; means that the result was at or above the limit of detection, &ldquo;1&rdquo;
indicates that the result was below the limit of detection. The other variable prefixed
LBX (ex., LBXFER) provides the analytic result for that analyte.&nbsp; For analytes with analytic
results below the lower limit of detection (ex., LBDFERLC=1),
an imputed fill value was placed in the analyte results field. This value is the
lower limit of detection divided by the square root of 2 (LLOD/sqrt[2]). </p>
<p style="line-height: 150%; margin-top: 0in; margin-right: 0in; margin-bottom: 10pt;">The lower limit of detection (LLOD in ng/mL)&nbsp;for LBXFER:&nbsp;<i style="mso-bidi-font-style: normal;"> </i></p>
<table style="border: currentColor; border-image: none; margin-top: auto; margin-right: auto; margin-bottom: auto; border-collapse: collapse; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 2.15pt .7pt 2.15pt .7pt;" border="1" cellspacing="0" cellpadding="0">
    <tbody>
        <tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes;">
            <td valign="top" style="padding: 2.15pt 0.7pt; border: 1pt solid windowtext; border-image: none; width: 111.45pt; background-color: transparent; mso-border-alt: solid windowtext .5pt;">
            <p style="margin: 0in -1pt 0pt 4.85pt; text-align: center; line-height: normal; mso-layout-grid-align: none;"><b>Va</b><b>riable Name</b></p>
            </td>
            <td valign="top" style="border-width: 1pt 1pt 1pt 0px; border-style: solid solid solid none; border-color: windowtext windowtext windowtext #000000; padding: 2.15pt 0.7pt; border-image: none; width: 178.35pt; background-color: transparent; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt;">
            <p style="margin: 0in -1pt 0pt 0in; text-align: center; line-height: normal; mso-layout-grid-align: none;"><b>S</b><b>A</b><b>S Label</b></p>
            </td>
            <td valign="top" style="border-width: 1pt 1pt 1pt 0px; border-style: solid solid solid none; border-color: windowtext windowtext windowtext #000000; padding: 2.15pt 0.7pt; border-image: none; width: 94.35pt; background-color: transparent; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt;">
            <p style="margin: 0in 0in 0pt; text-align: center; line-height: normal; mso-layout-grid-align: none;"><b>LLOD</b></p>
            </td>
        </tr>
        <tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
            <td valign="top" style="border-width: 0px 1pt 1pt; border-style: none solid solid; border-color: #000000 windowtext windowtext; padding: 2.15pt 0.7pt; border-image: none; width: 111.45pt; background-color: transparent; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt;">
            <p style="margin: 0in -1pt 0pt 4.85pt; text-align: center; line-height: normal; mso-layout-grid-align: none;">LBXFER</p>
            </td>
            <td valign="top" style="border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; border-color: #000000 windowtext windowtext #000000; padding: 2.15pt 0.7pt; width: 178.35pt; background-color: transparent; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt;">
            <p style="margin: 0in -1pt 0pt 4.85pt; text-align: center; line-height: normal; mso-layout-grid-align: none;">Ferritin</p>
            </td>
            <td valign="top" style="border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; border-color: #000000 windowtext windowtext #000000; padding: 2.15pt 0.7pt; width: 94.35pt; background-color: transparent; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt;">
            <p style="margin: 0in -1pt 0pt 4.85pt; text-align: center; line-height: normal; mso-layout-grid-align: none;">0.500 ng/mL</p>
            </td>
        </tr>
    </tbody>
</table>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 0pt;">&nbsp;</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 0pt;"><b>Ferritin regression
equations to compare 2015-16 and 1999-2010 data: </b></p>
<p style="line-height: 150%; margin-top: 0in; margin-right: 0in; margin-bottom: 10pt;">
</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">A method validation
(bridging) study was performed to compare results from an instrument change in the
2015-2016 cycle with earlier data. </p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">The Roche Mod E170
analyzer was used for most of 2015-2016 and replaced with the Roche Cobas e601 analyzer
in mid-2016. Randomly selected serum samples (n=188) from NHANES 2015-2016
participants, QC material, and proficiency testing specimens were measured
using both instruments and the results were used to conduct the analysis. On
average, ferritin values measured from the Roche e601 analyzer were 8.8% higher
than values from the Roche Mod E170 (p&lt;.0001). Data from the bridging study
indicated the correlation coefficient (<i style="mso-bidi-font-style: normal;">r</i>)
between the measurements was 0.999. Regression analyses were performed using Analyse-it,
v4.30.4. Given that the data showed proportional differences in variability, a
weighted Deming regression was chosen to adjust the ferritin results (ng/mL).The
forward and backward equations are below: </p>
<p style="margin: 0in 0.5in 12pt 120px; line-height: 15.95pt; text-indent: -0.75in; tab-stops: 1.75in;">Forward: &nbsp;&nbsp; <b style="mso-bidi-font-weight: normal;">Y</b> <i style="mso-bidi-font-style: normal;">(e601)</i> <b style="mso-bidi-font-weight: normal;">= 0.2243</b> (95%CI: -0.0069 &ndash; 0.4554) <b style="mso-bidi-font-weight: normal;">+ X</b> <i style="mso-bidi-font-style: normal;">(E170)</i>
<b style="mso-bidi-font-weight: normal;">* 1.079</b> (95%CI: 1.070 &ndash; 1.088)</p>
<p style="margin: 0in 0.5in 12pt 120px; line-height: 15.95pt; text-indent: -0.75in; tab-stops: 1.75in;">Backward:&nbsp; <b style="mso-bidi-font-weight: normal;">Y</b> <i style="mso-bidi-font-style: normal;">(E170)</i> <b style="mso-bidi-font-weight: normal;">= -0.2079 </b>(95%CI: -0.4233 &ndash; 0.0074) <b style="mso-bidi-font-weight: normal;">+ X</b> <i style="mso-bidi-font-style: normal;">(e601)</i>
<b style="mso-bidi-font-weight: normal;">* 0.9271</b> (95%CI: 0.9195 &ndash; 0.9348)</p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">These regression
equations should be used when examining trends of  ferritin&nbsp;data across
2015-2016 and 2009-2010 cycles, or combining 2015-2016 data with these previous
cycles. For analysis involving 2015-2016 data and data collected prior to 2009-2010
cycle, please refer to the documentation accompanying the 2009 -2010 (FERTIN_F)
and 2003-2004 (L06TFR_C) ferritin data for additional adjustments. </p>
<p style="line-height: 15.95pt; margin-top: 0in; margin-right: 0.5in; margin-bottom: 12pt;">Results in this
2015-2016 dataset from specimens analyzed using the Roche MOD E170 were
adjusted using the above forward regression equation.</p></div>
      <div id="References">
        <h2>References</h2>
        <ul>
          <li>Caudill, S.P., Schleicher, R.L., Pirkle, J.L. Multi-rule quality control for the age-related eye disease study. Statist. Med. (2008) 27(20):4094-40106.</li>
          <li>Westgard J.O., Barry P.L., Hunt M.R., Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem (1981) 27:493-501.</li>
        </ul>
      </div>
      <div id="Codebook">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number</dd>
            <dt>Target: </dt>
            <dd> Both males and females 1 YEARS -
			5 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXFER">LBXFER - Ferritin (ng/mL)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXFER</dd>
            <dt>SAS Label: </dt>
            <dd>Ferritin (ng/mL)</dd>
            <dt>English Text: </dt>
            <dd class="info">Ferritin (ng/mL)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 1 YEARS -
			5 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1.84 to 2300</td>
                <td class="values">Range of Values</td>
                <td class="values" align="right">2684</td>
                <td class="values" align="right">2684</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">568</td>
                <td class="values" align="right">3252</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDFERSI">LBDFERSI - Ferritin (ug/L)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDFERSI</dd>
            <dt>SAS Label: </dt>
            <dd>Ferritin (ug/L)</dd>
            <dt>English Text: </dt>
            <dd class="info">Ferritin (ug/L)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 1 YEARS -
			5 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1.84 to 2300</td>
                <td class="values">Range of Values</td>
                <td class="values" align="right">2684</td>
                <td class="values" align="right">2684</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">568</td>
                <td class="values" align="right">3252</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>